Docoh
Loading...

22 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
and to use the safety and efficacy data to design future clinical trials. Based on toxicology studies and healthy human volunteer studies, Processa
10-Q
2021 Q1
PCSA Processa Pharmaceuticals Inc
13 May 21
Quarterly report
4:30pm
clinical trials. Based on toxicology studies and healthy human volunteer studies, Processa and the FDA agreed that a PCS499 dose of 1.8 grams/day would
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
and efficacy data to design future clinical trials. Based on toxicology studies and healthy human volunteer studies, Processa and the FDA agreed … indication, conducting a healthy human volunteer trial, completing a Phase 2A clinical trial in patients with NL and initiating a Phase 2 clinical trial
10-Q
2020 Q3
PCSA Processa Pharmaceuticals Inc
12 Nov 20
Quarterly report
4:01pm
and efficacy data to design future clinical trials. Based on toxicology studies and healthy human volunteer studies, Processa and the FDA agreed that a PCS499 … and to use the collected safety and efficacy data to design future clinical trials. Based on toxicology studies and healthy human volunteer studies
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
clinical trials. Based on toxicology studies and healthy human volunteer studies, Processa and the FDA agreed that a PCS499 dose of 1.8 grams/day … on one indication, conducting a healthy human volunteer trial and presently completing a Phase 2A clinical trial in patients with NL. Although we have
S-1/A
pyqgsmi15
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
2lyp40
16 Sep 20
IPO registration (amended)
8:00pm
10-Q
kauk2gbxes
5 Aug 20
Quarterly report
3:32pm
S-1/A
b2dknd8688o7pzpez
17 Jul 20
IPO registration (amended)
5:25pm
10-Q
2rc4xautdd
15 May 20
Quarterly report
1:23pm
10-K
sca3e5zbytt
5 Mar 20
Annual report
7:00pm
S-1
61pudv volscl1
13 Dec 19
IPO registration
5:32pm
10-Q
xoe6hqr8yj7w xsb4
14 Nov 19
Quarterly report
11:45am
10-Q
7m8to5
13 Aug 19
Quarterly report
8:00pm
10-K/A
mllwcnir2p857jzaq8
5 Apr 19
Annual report (amended)
9:40pm
10-K
zqblcmnj1kb7t zrn
28 Mar 19
Annual report
5:25pm
424B3
jssfob jim7a0ec52qb
13 Nov 18
Prospectus supplement
9:39pm
10-Q
pzqo90 lshb3xbv
13 Nov 18
Quarterly report
9:37pm
424B3
ra1owb 6l
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
z0tf6btchj2d
30 Oct 18
IPO registration (amended)
4:19pm